There have been relatively few advances in the therapeutic options for the treatment of COPD, but a better understanding of the molecular mechanisms involved in the pathogenesis of COPD will undoubtedly lead to improved therapies in the future [18,19]. COPD involves an active inflammatory process and progressive destruction of the lungs, so that it should be possible to develop drugs that are able to halt this process and prevent the accelerated decline in lung function that characterizes the disease. Better understanding of the cellular and molecular mechanisms involved in COPD has identified several novel therapeutic targets (Fig. 11.3).
Was this article helpful?